Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120100250101456
Journal of Korean Medical Science
2010 Volume.25 No. 10 p.1456 ~ p.1461
Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction
Lee Min-Goo

Jeong Myung-Ho
Ahn Young-Keun
Chae Shung-Chull
Hur Seung-Ho
Hong Taek-Jong
Kim Young-Jo
Seong In-Whan
Chae Jei-Keon
Rhew Jay-Young
Chae In-Ho
Cho Myeong-Chan
Bae Jang-Ho
Rha Seung-Woon
Kim Chong-Jin
Choi Dong-Hoon
Jang Yang-Soo
Yoon Jung-Han
Chung Wook-Sung
Cho Jeong-Gwan
Seung Ki-Bae
Park Seung-Jung
Abstract
We sought to determine the prevalence of metabolic syndrome (MS) in patients with acute myocardial infarction and its effect on clinical outcomes. Employing data from the Korea Acute Myocardial Infarction Registry, a total of 1,990 patients suffered from acute ST-elevation myocardial infarction (STEMI) between November 2005 and December 2006 were categorized according to the National Cholesterol Education Program-Adult Treatment Panel III criteria of MS. Primary study outcomes included major adverse cardiac events (MACE) during one-year follow-up. Patients were grouped based on existence of MS: group I: MS (n=1,182, 777 men, 62.8¡¾12.3 yr); group II: Non-MS (n=808, 675 men, 64.2¡¾13.1 yr). Group I showed lower left ventricular ejection fraction (LVEF) (P=0.005). There were no differences between two groups in the coronary angiographic findings except for multivessel involvement (P=0.01). The incidence of in-hospital death was higher in group I than in group II (P=0.047), but the rates of composite MACE during one-year clinical follow-up showed no significant differences. Multivariate analysis showed that low LVEF, old age, MS, low high density lipoprotein cholesterol and multivessel involvement were associated with high in-hospital death rate. In conclusion, MS is an important predictor for in-hospital death in patients with STEMI.
KEYWORD
Metabolic Syndrome, Prognosis, Myocardial Infarction
FullTexts / Linksout information
  
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø